ArticleMolecular genetics and metabolism reports2021

The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb.

Roberta Resaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.